205 related articles for article (PubMed ID: 30021163)
21. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.
Bosse T; ter Haar NT; Seeber LM; v Diest PJ; Hes FJ; Vasen HF; Nout RA; Creutzberg CL; Morreau H; Smit VT
Mod Pathol; 2013 Nov; 26(11):1525-35. PubMed ID: 23702729
[TBL] [Abstract][Full Text] [Related]
22. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
[TBL] [Abstract][Full Text] [Related]
23. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2009 Apr; 22(4):522-9. PubMed ID: 19234438
[TBL] [Abstract][Full Text] [Related]
24. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
25. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
[TBL] [Abstract][Full Text] [Related]
26. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines.
Hsin IL; Shen HP; Chang HY; Ko JL; Wang PH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831139
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
Dong P; Xu Z; Jia N; Li D; Feng Y
Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
[TBL] [Abstract][Full Text] [Related]
28. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
29. Concomitant activation of AKT with extracellular-regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss.
Mori N; Kyo S; Sakaguchi J; Mizumoto Y; Ohno S; Maida Y; Hashimoto M; Takakura M; Inoue M
Cancer Sci; 2007 Dec; 98(12):1881-8. PubMed ID: 17924977
[TBL] [Abstract][Full Text] [Related]
30. Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer.
Bradford LS; Rauh-Hain A; Clark RM; Groeneweg JW; Zhang L; Borger D; Zukerberg LR; Growdon WB; Foster R; Rueda BR
Gynecol Oncol; 2014 May; 133(2):346-52. PubMed ID: 24561032
[TBL] [Abstract][Full Text] [Related]
31. Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancer.
Feigin ME; Akshinthala SD; Araki K; Rosenberg AZ; Muthuswamy LB; Martin B; Lehmann BD; Berman HK; Pietenpol JA; Cardiff RD; Muthuswamy SK
Cancer Res; 2014 Jun; 74(11):3180-94. PubMed ID: 24662921
[TBL] [Abstract][Full Text] [Related]
32. TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism.
Cheng J; Huang Y; Zhang X; Yu Y; Wu S; Jiao J; Tran L; Zhang W; Liu R; Zhang L; Wang M; Wang M; Yan W; Wu Y; Chi F; Jiang P; Zhang X; Wu H
Nat Commun; 2020 Apr; 11(1):1880. PubMed ID: 32312982
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol biogenesis is a PTEN-dependent actionable node for the treatment of endocrine therapy-refractory cancers.
Kaysudu I; Gungul TB; Atici S; Yilmaz S; Bayram E; Guven G; Cizmecioglu NT; Sahin O; Yesiloz G; Haznedaroglu BZ; Cizmecioglu O
Cancer Sci; 2023 Nov; 114(11):4365-4375. PubMed ID: 37706278
[TBL] [Abstract][Full Text] [Related]
34. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
Urick ME; Rudd ML; Godwin AK; Sgroi D; Merino M; Bell DW
Cancer Res; 2011 Jun; 71(12):4061-7. PubMed ID: 21478295
[TBL] [Abstract][Full Text] [Related]
35. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
[TBL] [Abstract][Full Text] [Related]
36. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
Zhu L; Wang X; Wang T; Zhu W; Zhou X
Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
[TBL] [Abstract][Full Text] [Related]
37. PTEN-deficient cancers depend on PIK3CB.
Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
[TBL] [Abstract][Full Text] [Related]
38. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
39. PI3K/PTEN/AKT Genetic Mouse Models of Endometrial Carcinoma.
Joshi A; Ellenson LH
Adv Exp Med Biol; 2017; 943():261-273. PubMed ID: 27910071
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.
Subramaniam KS; Tham ST; Mohamed Z; Woo YL; Mat Adenan NA; Chung I
PLoS One; 2013; 8(7):e68923. PubMed ID: 23922669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
